generation of these products may be modified in certain pathological conditions , such as atherosclerosis and diabetes , where prostacyclin synthesis is reduced and txa2 synthesis increased , resulting in a pro-thrombotic state .
C0003850
atherosclerosis
C0033567
prostacyclin